Outcome of 42nd Annual General Meeting of Kapil Cotex Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kapil Cotex Limited held its 42nd AGM on 25th September 2025, where shareholders approved several transformative resolutions. Key approvals include changing the company name to Skybiotech Healthcare Limited, altering the main object clause to reflect a new business direction, and increasing the authorized share capital. Shareholders also ratified the acquisition of equity shares of Skybiotech Life Sciences Private Limited (a Section 186 related-party transaction). Routine items approved include adoption of audited standalone and consolidated financial statements for FY ending March 2025, re-appointment of Mrs. Poonam Prakash Rathi as director, appointment of a new independent director (Mr. Vijay Sitaram Chitlange), and M/s. SM Dhumal & Associates as secretarial auditors. The meeting concluded at 11:53 AM.
This is a major business pivot from textiles to healthcare/biotech, signaled by the name change, acquisition of Skybiotech Life Sciences, and expansion of business objectives. Shareholders should watch for possible fundraising through the increased authorized share capital and a potential re-rating of the stock once the healthcare identity takes effect.